Treatments used among adolescent residential addiction treatment facilities in the United States, 2022
3 institutional releases
Published in Journal of the American Medical Association · View the paper (DOI)
A recent NIH-funded study found that only 1 in 4 residential addiction treatment facilities for adolescents under 18 years old offer buprenorphine to treat opioid use disorder. The study highlights a significant gap in access to evidence-based treatment among young people, with many facilities not offering this life-saving medication d...
Coverage from 3 institutions
- Only 1 in 4 adolescent treatment facilities offer buprenorphine for opioid use disorder NIH/National Institute on Drug Abuse · Jun 13, 2023 · first to report
- Teens rarely receive addiction medication in U.S. treatment centers Oregon Health & Science University · Jun 13, 2023
- Treatments used among adolescent residential addiction treatment facilities in the US JAMA Network · Jun 13, 2023